Almitas Capital LLC is an SEC-registered investment adviser based in Santa Monica, CA that reports managing 2 hedge funds on Form ADV. It reports $1.1 billion in regulatory assets under management. Its private funds, of all types, hold $1.1 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -11.2% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +12.5% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $1.1 billionForm ADV Item 5.F
- Gross assets of private funds
- $1.1 billionAll private fund types, Form ADV
- Hedge funds managed
- 22 private funds in total
- Employees
- 12Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 166705
- Latest Form ADV
- 05/08/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +1.0% | +14.8% |
| Q1 2026 | -12.1% | -4.6% |
| Q4 2025 | -8.5% | +2.4% |
| Q3 2025 | +16.0% | +7.8% |
| Q2 2025 | +19.2% | +10.4% |
| Q1 2025 | -11.2% | -4.5% |
| Q4 2024 | +5.1% | +2.1% |
| Q3 2024 | +7.3% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
The 50 largest of 146 share positions ($443,815,002) reported by Almitas Capital LLC on Form 13F for the quarter ended Sep 30, 2026, filed Nov 17, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Fidelity Wise Origin Bitcoin17.73%
- ASA Gold And Precious Mtls L9.45%
- Blackrock Mun Target Term TR7.31%
- Guggenheim Strategic Opportu3.17%
- Cornerstone Total Return FD2.75%
- Cornerstone Strategic Invest2.70%
- Pimco Dynamic Income Strateg2.69%
- FS Specialty Lending FD2.64%
- Cannae Hldgs Inc2.56%
- Blackrock Health Sciences Te2.26%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Fidelity Wise Origin Bitcoin | $78,681,759 | 17.73% | 1,083,174 | -20.62% |
| ASA Gold And Precious Mtls L | $41,961,130 | 9.45% | 752,666 | +19.64% |
| Blackrock Mun Target Term TR | $32,462,277 | 7.31% | 1,486,368 | +0.08% |
| Guggenheim Strategic Opportu | $14,048,470 | 3.17% | 1,650,819 | New |
| Cornerstone Total Return FD | $12,223,627 | 2.75% | 1,984,355 | +26.21% |
| Cornerstone Strategic Invest | $12,001,299 | 2.70% | 1,875,203 | +183.35% |
| Pimco Dynamic Income Strateg | $11,935,832 | 2.69% | 587,972 | +7.00% |
| FS Specialty Lending FD | $11,697,977 | 2.64% | 1,005,845 | +87.21% |
| Cannae Hldgs Inc | $11,371,818 | 2.56% | 741,318 | Unchanged |
| Blackrock Health Sciences Te | $10,034,345 | 2.26% | 600,859 | +18.49% |
| Design Therapeutics Inc | $7,485,221 | 1.69% | 595,483 | -42.01% |
| Nyli Cbre GBL Infr Megtrnds | $7,280,110 | 1.64% | 540,870 | -2.98% |
| Pgim Short Dur Hig YLD Opp F | $6,204,215 | 1.40% | 407,368 | +11.71% |
| Blackrock Cap Allocation Ter | $5,988,092 | 1.35% | 437,087 | New |
| Crescent Cap BDC Inc | $5,670,624 | 1.28% | 617,715 | +73.08% |
| Voya Emerging Mkts High Divi | $5,564,881 | 1.25% | 735,123 | +840.52% |
| Liberty All Star Equity FD | $5,338,479 | 1.20% | 925,213 | +15.89% |
| Pimco Calif Mun Income FD | $5,218,105 | 1.18% | 676,797 | -4.76% |
| Virtus Dividend Interest & P | $5,086,238 | 1.15% | 337,956 | New |
| Ishares TR | $4,792,700 | 1.08% | 69,946 | Unchanged |
| Elme Communities | $4,557,490 | 1.03% | 2,619,247 | Unchanged |
| Lyell Immunopharma Inc | $4,387,193 | 0.99% | 448,130 | -22.92% |
| Japan Smaller Capitalization | $4,241,336 | 0.96% | 336,614 | -12.88% |
| BNY Mellon Strategic Mun BD | $4,217,005 | 0.95% | 809,406 | +6.78% |
| Eaton Vance Tax-managed Dive | $4,181,870 | 0.94% | 297,642 | New |
| The Central And Eastern Eu I | $4,180,334 | 0.94% | 221,416 | +27.80% |
| Aberdeen Mun Income FD | $4,114,386 | 0.93% | 848,327 | -3.44% |
| Nuveen S&P 500 Dynamic Overw | $3,770,721 | 0.85% | 203,933 | -37.62% |
| DTF Tax-free Income 2028 Ter | $3,708,278 | 0.84% | 329,332 | -7.25% |
| Clough Global Opportunities | $3,637,742 | 0.82% | 681,225 | -4.02% |
| Ladder Cap Corp | $3,583,464 | 0.81% | 410,477 | +20.56% |
| Voya Asia Pac High Div Eqt I | $3,496,090 | 0.79% | 393,261 | New |
| Franklin BSP Rlty TR Inc | $3,462,000 | 0.78% | 541,784 | +81.69% |
| Mexico FD Inc | $3,172,235 | 0.71% | 155,578 | -8.92% |
| Ennis Inc | $3,127,900 | 0.70% | 138,956 | Unchanged |
| Pimco New York Mun FD II | $2,855,121 | 0.64% | 466,523 | -0.19% |
| Nuveen Va Quality Mun Incom | $2,845,744 | 0.64% | 308,649 | New |
| Alx Oncology Hldgs Inc | $2,839,039 | 0.64% | 2,042,474 | -30.49% |
| Calamos LNG SHR Eqt Dynamic | $2,753,152 | 0.62% | 219,200 | +468.11% |
| First TR High Yield Opprt 20 | $2,554,593 | 0.58% | 198,801 | Unchanged |
| Clough Global Equity FD | $2,473,855 | 0.56% | 331,172 | Unchanged |
| Saba Capital Income & Opport | $2,457,733 | 0.55% | 308,373 | -11.34% |
| Liberty All-star Growth FD I | $2,390,544 | 0.54% | 473,375 | +1.46% |
| Amylyx Pharmaceuticals Inc | $2,383,057 | 0.54% | 81,892 | -91.60% |
| TPG Re Fin TR Inc | $2,364,302 | 0.53% | 377,684 | +4.14% |
| Columbia Seligm Prem Tech GR | $2,335,070 | 0.53% | 43,427 | New |
| SRH Total Return Fund Inc | $2,323,637 | 0.52% | 133,773 | Unchanged |
| Ishares TR | $2,247,004 | 0.51% | 5,868 | New |
| Bluerock PVT Real Estate FD | $2,113,467 | 0.48% | 168,538 | New |
| Pulmonx Corp | $2,062,873 | 0.46% | 1,080,038 | +1.49% |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 35 new positions, 18 sold out, 36 increased, 28 reduced and 47 unchanged.
Number of positions (a count, not dollars)
- New positions35
- Increased36
- Unchanged47
- Reduced28
- Sold out18
New positions
| Stock | Value | Shares |
|---|---|---|
| Guggenheim Strategic Opportu | $14,048,470 | 1,650,819 |
| Blackrock Cap Allocation Ter | $5,988,092 | 437,087 |
| Virtus Dividend Interest & P | $5,086,238 | 337,956 |
| Eaton Vance Tax-managed Dive | $4,181,870 | 297,642 |
| Voya Asia Pac High Div Eqt I | $3,496,090 | 393,261 |
| Nuveen Va Quality Mun Incom | $2,845,744 | 308,649 |
| Columbia Seligm Prem Tech GR | $2,335,070 | 43,427 |
| Ishares TR | $2,247,004 | 5,868 |
| Bluerock PVT Real Estate FD | $2,113,467 | 168,538 |
| Pimco Dynamic Income FD | $1,936,715 | 138,041 |
| Blackrock Muniassets FD Inc | $1,681,516 | 176,075 |
| DWS Mun Income TR | $1,221,950 | 150,858 |
| Cohen & Steers QTY Inc R | $1,000,827 | 91,819 |
| Goldman Sachs Group Inc | $839,136 | 932 |
| Morgan Stanley | $596,214 | 3,170 |
| Bank Of Amer Corp | $537,551 | 9,876 |
| Wells Fargo & Co | $448,680 | 5,605 |
| Wheeler Real Estate Invt TR | $448,035 | 5,271 |
| Blue Owl Capital Corporation | $419,600 | 40,000 |
| Saba Capital Income & Oprnt | $327,942 | 54,566 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Tortoise Energy Infrstrctr C | $6,939,453 | 161,872 |
| Schwab Strategic TR | $4,702,848 | 198,600 |
| First TR SR Fltg Rate Income | $4,502,256 | 466,072 |
| Fulgent Genetics Inc | $2,150,434 | 104,797 |
| Rallybio Corp | $1,930,912 | 120,682 |
| Arrowmark Financial Corp | $993,981 | 50,843 |
| Toro Corp | $487,000 | 100,000 |
| Credit Suisse High Yield Cre | $439,706 | 247,026 |
| Abrdn Natl Mun Income FD | $385,982 | 37,221 |
| Aberdeen Multi-market Income | $366,247 | 83,238 |
| Destra Multi-alternative FD | $338,044 | 45,193 |
| Eos Energy Enterprises Inc | $294,000 | 50,000 |
| Playstudios Inc | $289,154 | 579,467 |
| Blackrock CR Allocation | $190,705 | 18,660 |
| Blackrock Core BD TR | $154,166 | 16,812 |
| Nuveen CR Strategies Income | $136,279 | 28,041 |
| Blackrock Munihldngs Cali | $130,781 | 11,900 |
| Cohen & Steers Quality Incom | $745 | 50,000 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Cornerstone Strategic Invest | +1,213,414 | +183.35% | $12,001,299 | 1,875,203 |
| ASA Gold And Precious Mtls L | +123,545 | +19.64% | $41,961,130 | 752,666 |
| FS Specialty Lending FD | +468,550 | +87.21% | $11,697,977 | 1,005,845 |
| Voya Emerging Mkts High Divi | +656,962 | +840.52% | $5,564,881 | 735,123 |
| Cornerstone Total Return FD | +412,046 | +26.21% | $12,223,627 | 1,984,355 |
| Crescent Cap BDC Inc | +260,810 | +73.08% | $5,670,624 | 617,715 |
| Calamos LNG SHR Eqt Dynamic | +180,616 | +468.11% | $2,753,152 | 219,200 |
| Blackrock Health Sciences Te | +93,764 | +18.49% | $10,034,345 | 600,859 |
| Franklin BSP Rlty TR Inc | +243,594 | +81.69% | $3,462,000 | 541,784 |
| Blackrock Science & Technolo | +38,177 | +142.40% | $1,911,918 | 64,987 |
| The Central And Eastern Eu I | +48,162 | +27.80% | $4,180,334 | 221,416 |
| Pimco Dynamic Income Strateg | +38,477 | +7.00% | $11,935,832 | 587,972 |
| Liberty All Star Equity FD | +126,871 | +15.89% | $5,338,479 | 925,213 |
| Nuveen Churchill Direct Lend | +64,531 | +91.98% | $1,513,927 | 134,691 |
| Pgim Short Dur Hig YLD Opp F | +42,694 | +11.71% | $6,204,215 | 407,368 |
| Ladder Cap Corp | +70,000 | +20.56% | $3,583,464 | 410,477 |
| Starwood Ppty TR Inc | +45,000 | +63.38% | $1,566,000 | 116,000 |
| Blackstone Long Short CR Inc | +28,475 | +113.51% | $565,594 | 53,560 |
| BNY Mellon High Yield Strate | +131,724 | +165.35% | $469,284 | 211,389 |
| Blackstone Seni Fltn Rat 202 | +20,860 | +46.91% | $846,036 | 65,331 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc | -892,989 | -91.60% | $2,383,057 | 81,892 |
| Fidelity Wise Origin Bitcoin | -281,348 | -20.62% | $78,681,759 | 1,083,174 |
| An2 Therapeutics Inc | -1,120,061 | -76.24% | $1,857,042 | 349,068 |
| Design Therapeutics Inc | -431,410 | -42.01% | $7,485,221 | 595,483 |
| Nuveen S&P 500 Dynamic Overw | -122,974 | -37.62% | $3,770,721 | 203,933 |
| Nuveen Floating Rate Income | -205,111 | -47.13% | $1,711,922 | 230,097 |
| Brightspire Capital Inc | -350,708 | -45.60% | $1,602,185 | 418,325 |
| Lyell Immunopharma Inc | -133,277 | -22.92% | $4,387,193 | 448,130 |
| Alx Oncology Hldgs Inc | -895,957 | -30.49% | $2,839,039 | 2,042,474 |
| Mfa Finl Inc | -102,348 | -79.91% | $202,043 | 25,738 |
| Cohen & Steers Infrastructur | -26,810 | -69.52% | $289,687 | 11,752 |
| Japan Smaller Capitalization | -49,761 | -12.88% | $4,241,336 | 336,614 |
| High Income Secs FD | -115,875 | -55.36% | $482,187 | 93,447 |
| Alliancebernstein Natl Mun I | -61,529 | -50.85% | $566,692 | 59,464 |
| Saba Capital Income & Opport | -39,453 | -11.34% | $2,457,733 | 308,373 |
| Mexico FD Inc | -15,236 | -8.92% | $3,172,235 | 155,578 |
| DTF Tax-free Income 2028 Ter | -25,757 | -7.25% | $3,708,278 | 329,332 |
| Pimco Calif Mun Income FD | -33,807 | -4.76% | $5,218,105 | 676,797 |
| Nyli Cbre GBL Infr Megtrnds | -16,592 | -2.98% | $7,280,110 | 540,870 |
| Eaton Vance Limited Duration | -22,059 | -47.54% | $205,673 | 24,340 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| Nuveen Core Plus Impact Fund | 13G amendment | 0% | 2,738 | Nov 16, 2026 | SEC.gov ↗ |
| DTF Tax-Free Income 2028 Term Fund Inc | 13G amendment | 4.7% | 329,332 | Nov 16, 2026 | SEC.gov ↗ |
| MONROE CAPITAL Corp | 13G amendment | 0% | 0 | Aug 21, 2026 | SEC.gov ↗ |
| MFS Investment Grade Municipal Trust | 13G amendment | 0% | 0 | Aug 21, 2026 | SEC.gov ↗ |
| MFS High Yield Municipal Trust | 13G amendment | 0% | 0 | Aug 21, 2026 | SEC.gov ↗ |
| AN2 Therapeutics, Inc. | 13G amendment | 4.1% | 1,479,129 | May 15, 2026 | SEC.gov ↗ |
| Pioneer Floating Rate Fund, Inc. | 13G | 5.7% | 699,986 | Feb 17, 2026 | SEC.gov ↗ |
| Abrdn Japan Equity Fund, Inc. | 13G | 6.9% | 490,174 | Feb 17, 2026 | SEC.gov ↗ |
| Pioneer Municipal High Income Fund, Inc. | 13G | 0% | 0 | Nov 14, 2025 | SEC.gov ↗ |
| Pioneer High Income Fund, Inc. | 13G | 0% | 0 | Nov 14, 2025 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 14, 2025, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Hedge funds filing Form D (2)
Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.
Private funds reported on Form ADV (2)
As reported in the adviser's Form ADV filed Mar 28, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures